Literature DB >> 15128304

Purification and characterization of Helicobacter pylori arginase, RocF: unique features among the arginase superfamily.

David J McGee1, Jovanny Zabaleta, Ryan J Viator, Traci L Testerman, Augusto C Ochoa, George L Mendz.   

Abstract

The urea cycle enzyme arginase (EC 3.5.3.1) hydrolyzes l-arginine to l-ornithine and urea. Mammalian arginases require manganese, have a highly alkaline pH optimum and are resistant to reducing agents. The gastric human pathogen, Helicobacter pylori, also has a complete urea cycle and contains the rocF gene encoding arginase (RocF), which is involved in the pathogenesis of H. pylori infection. Its arginase is specifically involved in acid resistance and inhibits host nitric oxide production. The rocF gene was found to confer arginase activity to Escherichia coli; disruption of plasmid-borne rocF abolished arginase activity. A translationally fused His(6)-RocF was purified from E. coli under nondenaturing conditions and had catalytic activity. Remarkably, the purified enzyme had an acidic pH optimum of 6.1. Both purified arginase and arginase-containing H. pylori extracts exhibited optimal catalytic activity with cobalt as a metal cofactor; manganese and nickel were significantly less efficient in catalyzing the hydrolysis of arginine. Viable H. pylori or E. coli containing rocF had significantly more arginase activity when grown with cobalt in the culture medium than when grown with manganese or no divalent metal. His(6)-RocF arginase activity was inhibited by low concentrations of reducing agents. Antibodies raised to purified His(6)-RocF reacted with both H. pylori and E. coli extracts containing arginase, but not with extracts from rocF mutants of H. pylori or E. coli lacking the rocF gene. The results indicate that H. pylori RocF is necessary and sufficient for arginase activity and has unparalleled features among the arginase superfamily, which may reflect the unique gastric ecological niche of this organism.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15128304     DOI: 10.1111/j.1432-1033.2004.04105.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  33 in total

1.  Crystallization and preliminary crystallographic studies of Helicobacter pylori arginase.

Authors:  Jinyong Zhang; Xiaoli Zhang; Xuhu Mao; Quanming Zou; Defeng Li
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2011-05-26

2.  Construction of a highly efficient Bacillus subtilis 168 whole-cell biocatalyst and its application in the production of L-ornithine.

Authors:  Meizhou Wang; Meijuan Xu; Zhiming Rao; Taowei Yang; Xian Zhang
Journal:  J Ind Microbiol Biotechnol       Date:  2015-08-29       Impact factor: 3.346

Review 3.  Intestinal microbiome and digoxin inactivation: meal plan for digoxin users?

Authors:  Lingeng Lu; Yixing Wu; Lingjun Zuo; Xingguang Luo; Peter J Large
Journal:  World J Microbiol Biotechnol       Date:  2013-10-09       Impact factor: 3.312

4.  Coagulase-negative Staphylococci favor conversion of arginine into ornithine despite a widespread genetic potential for nitric oxide synthase activity.

Authors:  María Sánchez Mainar; Stefan Weckx; Frédéric Leroy
Journal:  Appl Environ Microbiol       Date:  2014-10-03       Impact factor: 4.792

5.  Replacing Mn(2+) with Co(2+) in human arginase i enhances cytotoxicity toward l-arginine auxotrophic cancer cell lines.

Authors:  Everett M Stone; Evan S Glazer; Lynne Chantranupong; Paul Cherukuri; Robert M Breece; David L Tierney; Steven A Curley; Brent L Iverson; George Georgiou
Journal:  ACS Chem Biol       Date:  2010-03-19       Impact factor: 5.100

6.  Structure and function of non-native metal clusters in human arginase I.

Authors:  Edward L D'Antonio; Yang Hai; David W Christianson
Journal:  Biochemistry       Date:  2012-10-12       Impact factor: 3.162

Review 7.  Arginine depriving enzymes: applications as emerging therapeutics in cancer treatment.

Authors:  Neha Kumari; Saurabh Bansal
Journal:  Cancer Chemother Pharmacol       Date:  2021-07-26       Impact factor: 3.333

Review 8.  Modulation of the arginase pathway in the context of microbial pathogenesis: a metabolic enzyme moonlighting as an immune modulator.

Authors:  Priyanka Das; Amit Lahiri; Ayan Lahiri; Dipshikha Chakravortty
Journal:  PLoS Pathog       Date:  2010-06-17       Impact factor: 6.823

Review 9.  Arginase: an emerging key player in the mammalian immune system.

Authors:  Markus Munder
Journal:  Br J Pharmacol       Date:  2009-09-17       Impact factor: 8.739

10.  Enzymatic Activity of Xyloglucan Xylosyltransferase 5.

Authors:  Alan T Culbertson; Yi-Hsiang Chou; Adrienne L Smith; Zachary T Young; Alesia A Tietze; Sylvain Cottaz; Régis Fauré; Olga A Zabotina
Journal:  Plant Physiol       Date:  2016-05-20       Impact factor: 8.340

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.